Aperio Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $149K | Buy |
37,381
+4,105
| +12% | +$16.4K | ﹤0.01% | 2355 |
|
|
2020
Q3 | $90K | Buy |
33,276
+7,329
| +28% | +$19.8K | ﹤0.01% | 2327 |
|
|
2020
Q2 | $71K | Buy |
25,947
+514
| +2% | +$1.41K | ﹤0.01% | 2289 |
|
|
2020
Q1 | $60K | Buy |
25,433
+5,646
| +29% | +$13.3K | ﹤0.01% | 2271 |
|
|
2019
Q4 | $93K | Buy |
19,787
+1,996
| +11% | +$9.38K | ﹤0.01% | 2274 |
|
|
2019
Q3 | $60K | Buy |
17,791
+3,392
| +24% | +$11.4K | ﹤0.01% | 2275 |
|
|
2019
Q2 | $47K | Buy |
+14,399
| New | +$47K | ﹤0.01% | 2547 |
|